Increased osteoprotegerin level is associated with impaired cardiovagal modulation in type-2 diabetic patients treated with oral antidiabetic drugs.

M R JasmineNivedita NandaJayaprakash SahooS VelkumaryG K Pal

Published in: BMC cardiovascular disorders (2020)

T2DM patients receiving OAD had higher cardiometabolic risks compared to age, gender and body composition-matched healthy individuals. Increased level of OPG is linked to decreased cardiovagal modulation in T2DM patients.

Keyphrases

body composition
end stage renal disease
resistance training
newly diagnosed
ejection fraction
bone mineral density
mental health
type diabetes
immune response
metabolic syndrome
human health
risk assessment
inflammatory response
toll like receptor
postmenopausal women
weight loss